Exact Mass: 429.20120920000005

Exact Mass Matches: 429.20120920000005

Found 75 metabolites which its exact mass value is equals to given mass value 429.20120920000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

7-Benzylidenenaltrexone

7-Benzylidenenaltrexone

C27H27NO4 (429.19399820000007)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists

   

Abiraterone sulfate

[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate

C24H31NO4S (429.19736860000006)


Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)

   

7-Benzylidenenaltrexone

4-(cyclopropylmethyl)-10,17-dihydroxy-15-(phenylmethylidene)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one

C27H27NO4 (429.19399820000007)


   

Hippuryl-histidyl-leucine

2-[[2-[(2-benzamidoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid

C21H27N5O5 (429.20120920000005)


   

2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid

2-{2-[2-(4-phenoxy-2-propylphenoxy)ethyl]-1H-indol-5-yl}acetic acid

C27H27NO4 (429.19399820000007)


   

Maybridge4_000051

Maybridge4_000051

C23H28FN3O4 (429.20637400000004)


   

HMS1663K08

HMS1663K08

C19H26F3N5O3 (429.1987642)


   

8-Benzylcanadine

8-Benzylcanadine

C27H27NO4 (429.19399820000007)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170

   

Gly-Trp-Ala-Pro

Gly-Trp-Ala-Pro

C21H27N5O5 (429.20120920000005)


   

Pro Trp Gln

Pro Trp Gln

C21H27N5O5 (429.20120920000005)


   

Versicamide A

Versicamide A

C26H27N3O3 (429.20523120000007)


   

Carneamide B

Carneamide B

C26H27N3O3 (429.20523120000007)


   

Ala Gly Pro Trp

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C21H27N5O5 (429.20120920000005)


   

Ala Gly Trp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Ala Pro Gly Trp

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-(1H-indol-3-yl)propanoic acid

C21H27N5O5 (429.20120920000005)


   

Ala Pro Trp Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]acetic acid

C21H27N5O5 (429.20120920000005)


   

Ala Trp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Ala Trp Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H27N5O5 (429.20120920000005)


   

Gly Ala Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

C21H27N5O5 (429.20120920000005)


   

Gly Ala Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Gly Pro Ala Trp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanoic acid

C21H27N5O5 (429.20120920000005)


   

Gly Pro Trp Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]propanoic acid

C21H27N5O5 (429.20120920000005)


   

Gly Trp Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Gly Trp Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C21H27N5O5 (429.20120920000005)


   

Trp Pro Gln

Trp Pro Gln

C21H27N5O5 (429.20120920000005)


   

Gln Trp Pro

Gln Trp Pro

C21H27N5O5 (429.20120920000005)


   

Pro Ala Gly Trp

(2S)-3-(1H-indol-3-yl)-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C21H27N5O5 (429.20120920000005)


   

Pro Ala Trp Gly

2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C21H27N5O5 (429.20120920000005)


   

Pro Gly Ala Trp

(2S)-3-(1H-indol-3-yl)-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C21H27N5O5 (429.20120920000005)


   

Pro Gly Trp Ala

(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C21H27N5O5 (429.20120920000005)


   

Pro Trp Ala Gly

2-[(2S)-2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C21H27N5O5 (429.20120920000005)


   

Trp Gln Pro

Trp Gln Pro

C21H27N5O5 (429.20120920000005)


   

Pro Trp Gly Ala

(2S)-2-{2-[(2S)-3-(1H-indol-3-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C21H27N5O5 (429.20120920000005)


   

Pro Gln Trp

Pro Gln Trp

C21H27N5O5 (429.20120920000005)


   

Gln Pro Trp

Gln Pro Trp

C21H27N5O5 (429.20120920000005)


   

Trp Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Trp Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H27N5O5 (429.20120920000005)


   

Trp Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C21H27N5O5 (429.20120920000005)


   

Trp Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C21H27N5O5 (429.20120920000005)


   

Trp Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C21H27N5O5 (429.20120920000005)


   

Trp Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C21H27N5O5 (429.20120920000005)


   

(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID

(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID

C27H27NO4 (429.19399820000007)


   

4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID

4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID

C23H23N7O2 (429.1913138)


   

Hippuryl-His-Leu-OH

Hippuryl-His-Leu-OH

C21H27N5O5 (429.20120920000005)


   

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)

Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)

C25H27N5S (429.19870620000006)


   

3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one

3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one

C23H28FN3O4 (429.20637400000004)


   

17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate

17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate

C21H32ClNO6 (429.19180420000004)


   

6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone

6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone

C23H23N7O2 (429.1913138)


   

(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

C27H27NO4 (429.19399820000007)


   

(+)-Pyridinoline

(+)-Pyridinoline

C18H29N4O8+ (429.1985294)


   

Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-

Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-

C27H27NO4 (429.19399820000007)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists

   

2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile

2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile

C26H27N3O3 (429.20523120000007)


   

4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester

4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester

C23H31N3O3S (429.20860160000007)


   

2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide

2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide

C23H31N3O3S (429.20860160000007)


   

1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester

1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester

C26H27N3O3 (429.20523120000007)


   

(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

C27H27NO4 (429.19399820000007)


   

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide

C21H27N5O5 (429.20120920000005)


   

Gln-Trp-Pro

Gln-Trp-Pro

C21H27N5O5 (429.20120920000005)


   

Pro-Gln-Trp

Pro-Gln-Trp

C21H27N5O5 (429.20120920000005)


   

Gln-Pro-Trp

Gln-Pro-Trp

C21H27N5O5 (429.20120920000005)


   

Pro-Trp-Gln

Pro-Trp-Gln

C21H27N5O5 (429.20120920000005)


   

Trp-Gln-Pro

Trp-Gln-Pro

C21H27N5O5 (429.20120920000005)


   

Trp-Pro-Gln

Trp-Pro-Gln

C21H27N5O5 (429.20120920000005)


   

(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione

(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione

C26H27N3O3 (429.20523120000007)


   

(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione

(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione

C26H27N3O3 (429.20523120000007)


   

[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate

[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate

C24H31NO4S (429.19736860000006)


   

ST 18:1;O7;Gly

ST 18:1;O7;Gly

C20H31NO9 (429.19987160000005)


   

4F 4PP (oxalate)

4F 4PP (oxalate)

C24H28FNO5 (429.19514100000004)


4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].